Keyword: Anti-PD-L1

News

Maya Martinez-Davis to Head Oncology at Merck KGaA

14.04.2016 - With immediate effect, Merck KGaA has appointed Maya Martinez-Davis (46) as global head of oncology for its biopharma business, succeeding Andrew Schiermeier. She will be based in...

News

Merck KGaA and Pfizer to Join Forces on Oncology Drug

21.11.2014 - German chemicals and pharmaceuticals producer Merck KGaA has announced a global alliance with US drugmaker Pfizer to jointly develop and commercialize Merck's anti-PD-L1, an...